Form 4 for OMDA Omada Health, Inc.
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-05 · accession 0001610717-26-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-05 | OMDA | Duffy Sean P. | CEO, Dir | A - Grant | $0.00 | +323.5K | 441.1K | +275% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | A | A | 323,529 | $0.00 | 441,127 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. (F2) The number of shares beneficially owned reported in Column 5 is as of the date of this filing and takes into account transactions reported on a Form 4 filed on 3/11/2026. |